References
- Schilsky R L, Anderson T. Hypomagnesiemia and renal magnesium waisting in patients receiving cisplatin. Ann Int Med 1979; 90: 929–31
- Dentino M, Luft C F, Veem M N, Williams S D, Einhorn L H. Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer 1978; 41: 1274–81
- Goldstein R S, Mayor G M. The nephrotoxicity of cisplatin. Life Sci 1983; 32: 685–90
- Thomsen K, Holstein-Rathlou N-H, Leyssac P P. Comparison of three measures of proximal tubular reabsorption: lithium clearance, occlusion time and micropuncture. Amer J Physiol 1981; 241: F348–F355
- Thomsen K. Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron 1984; 37: 217–23
- Einhorn L H, Donohue J P. Cisdiamminedichloro-platinum, vinblastin and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Int Med 1977; 87: 293–8
- Brøchner-Mortensen J, Rødbro P. Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 1976; 36: 35–43
- Amdisen A. The estimation of lithium in urine. Lithium Research and Therapy, F N Johnson. Academic Press, London 1975; 181–95
- Hayslett J P, Kashgarian M. A micropuncture study of the renal handling of lithium. Pflügers Arch 1979; 380: 159–63
- Shirley D G, Walter S J, Thomsen K. A comparison of micropuncture and lithium clearance methods in the assessment of renal tubular function in rats with diabetes insipidus. Pflügers Arch 1983; 399: 266–70
- Madias N E, Harrington J T. Platinum nephrotoxicity. Amer J Med 1979; 65: 307–14
- Gonzales-Vitale J C, Hayes D M, Cvitkovic E, Sternberg S S. The renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer 1977; 39: 1362–71
- Daugaard G, Abildgaard U, Holstein-Rathlou N-H, Leyssac P P, Amtorp O, Dikhoff T G. Acute effect of cisplatin on renal hemodynamics and tubular function in dog kidneys. Renal Physiol 1986; 9: 308–16
- Sørensen P G, Nissen M N, Groth S, Rørth M. Beta-2-microglobulin excretion: an indication of long-term nephrotoxicity during cisplatin treatment. Cancer Chemother Pharmacol 1985; 14: 247–9